Aura Biosciences, Inc.
AURA
$5.36
-$0.04-0.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.67% | 5.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.69% | 2.06% | |||
| Operating Income | -19.69% | -2.06% | |||
| Income Before Tax | -22.91% | -3.26% | |||
| Income Tax Expenses | -44.19% | -- | |||
| Earnings from Continuing Operations | -22.77% | -3.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.77% | -3.47% | |||
| EBIT | -19.69% | -2.06% | |||
| EBITDA | -20.06% | -2.09% | |||
| EPS Basic | -22.09% | -3.24% | |||
| Normalized Basic EPS | -22.21% | -3.04% | |||
| EPS Diluted | -22.09% | -3.24% | |||
| Normalized Diluted EPS | -22.21% | -3.04% | |||
| Average Basic Shares Outstanding | 0.55% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.55% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||